InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,616.84
(
-0.32%
)
US TECH 100
18,991.20
(
-1.09%
)
Dow Jones
41,240.52
(
0.16%
)
Brent Oil
80.19
(
-0.10%
)
Bitcoin
63,077.83
(
0.32%
)
Post# of 252977
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: None

Thursday, 04/13/2017 1:49:40 PM

Thursday, April 13, 2017 1:49:40 PM

Post# of 252977
Interesting preclinical paper - FGEN's roxadustat dosed intermittently not only did not enhance tumor growth (as some have feared it might) but sensitized them to cisplatin:

https://www.nature.com/articles/srep45621
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up